profit from every €100 of sales.
€0€100
Gerresheimer
€31.08-1.52% today
+15.5% since Dec 21, 25
1-year low €15.701-year high €33.00
Trading close to its highest price of the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average, 2021 to 2024.
0%20% a year
You pay €9.78 for every €1 of profit it makes in a year.
CheapExpensive
of earnings would pay off all its debt.
No debt5 years
Money in, money out
What Gerresheimer sold, what it kept, and what it did with the cash.
Sales went from €1.50 billion in 2021 to €2.04 billion in 2024, with €110 million of profit last year.
SalesProfit
Gerresheimer vs. similar companies
Gerresheimer grows in the middle of these 5 and is the cheapest for its profits.
| Company | Profit from €100 of sales | Sales growth a year | Price per €1 of profit |
|---|---|---|---|
| Gerresheimer | 9.8× · Cheap | ||
 Intuitive Surgical | 53.8× · Expensive | ||
 EssilorLuxottica Société anonyme | 36.1× · Expensive | ||
 Becton, Dickinson and | 35.4× · Expensive | ||
 Medline | 44.8× · Expensive |
AI analysis
An AI analyst reads Gerresheimer's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of EUR | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| 1,498 | 1,817 | 1,990 | 2,036 | |
| 446 | 547 | 597 | 608 | |
| 189 | 194 | 229 | 234 | |
| 294 | 340 | 404 | 406 | |
| 84 | 96 | 116 | 110 | |
| 2.67 | 3.06 | 3.48 | 3.18 | |
| 29.8% | 30.1% | 30.0% | 29.9% | |
| 12.6% | 10.7% | 11.5% | 11.5% | |
| 5.6% | 5.3% | 5.8% | 5.4% |
Balance sheet
| In millions of EUR | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Total assets | 2,877 | 3,354 | 3,429 | 3,809 |
| Cash | 114 | 113 | 122 | 186 |
| Total debt | 1,134 | 1,221 | 1,041 | 1,282 |
| Total liabilities | 1,863 | 2,085 | 1,957 | 2,270 |
| 994 | 1,243 | 1,446 | 1,512 | |
| 31 | 31 | 33 | 35 | |
| 4.9% | 4.8% | 6.1% | 5.2% | |
| 8.4% | 7.7% | 8.0% | 7.3% |
Cash flow
| In millions of EUR | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| 212 | 222 | 294 | 240 | |
| 204 | 241 | 328 | 370 | |
| 8 | -20 | -34 | -130 | |
| Dividends paid | – | – | – | – |
| – | – | – | – | |
| – | – | – | – |
Valuation
- 9.8×
- –
- 1.63
- 0.6×
- 0.5×
- –
- 5.3×
- -12.1%
- 10.2%
- –
Profitability
- 29.9%
- 11.5%
- 5.4%
- –
- 5.2%
- 5.3%
- –
- –
- –
- –
Growth
- +10.8%
- +6.0%
- –
- –
- +3.2%
Financial health
- 2.7×
- 0.85
- –
- 3.4×
- 1.01
- –
- –
How it ranks in Healthcare
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Bottom 45%of 964
Top 49%of 898
Top 9%of 651
Top 50%of 911
Bottom 7%of 991
News
No recent news on file.
Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
1/7Passes 1 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
37No pass
Benjamin Graham
80Pass
Philip Fisher
33No pass
Peter Lynch
43No pass
Joel Greenblatt
45No pass
Charlie Munger
20No pass
Terry Smith
15No pass
Questions about Gerresheimer
Is Gerresheimer a good stock to buy?
A business with weak numbers, and the price looks low. 1 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the Gerresheimer AI analysis
What does Gerresheimer do?
Gerresheimer AG, together with its subsidiaries, provides medicine packaging, drug delivery devices, and solutions in Germany and internationally. The company operates through three divisions: Plastics & Devices, Primary Packaging Glass, and Advanced Technologies. It is in Medical Instruments & Supplies.
Is Gerresheimer stock halal?
No. Gerresheimer does not pass our halal screen: its debt is 119% of its market value, at or above the 33% limit. How we check
Who are Gerresheimer's competitors?
The largest listed companies in the same industry are Intuitive Surgical, EssilorLuxottica Société anonyme, Becton, Dickinson and and Medline. The peers table on this page compares their profit, growth and price with Gerresheimer's.
Prices: daily closes to Nov 13, 2026. Fundamentals: company reports via invest-like data.